Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatological Disorders”

30,700 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30,700 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Testing effectiveness (Phase 2)Looking for participantsNCT06178159
What this trial is testing

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
RemeGen Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT00565279
What this trial is testing

Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Astion Pharma A/S 300
Not applicableUnknownNCT00114296
What this trial is testing

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 80
Not applicableStudy completedNCT03677427
What this trial is testing

Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery

Who this might be right for
Breast Cancer
University Hospital, Ghent 488
Post-approval studies (Phase 4)Study completedNCT04080661
What this trial is testing

Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 82
Testing effectiveness (Phase 2)WithdrawnNCT01933061
What this trial is testing

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Celgene Corporation
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Not applicableStudy completedNCT03949270
What this trial is testing

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

Who this might be right for
Breast CancerAdherence, MedicationSide Effect
Yale University 400
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableStudy completedNCT02050594
What this trial is testing

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

Who this might be right for
Melanoma
Bristol-Myers Squibb 6
Not applicableUnknownNCT06267066
What this trial is testing

Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus

Who this might be right for
Lichen Simplex Chronicus
Cairo University 60
Not applicableStudy completedNCT03894956
What this trial is testing

Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa (HS)
AbbVie 46
Early research (Phase 1)Study completedNCT00687622
What this trial is testing

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

Who this might be right for
Solid Tumours
GlaxoSmithKline 206
Large-scale testing (Phase 3)Looking for participantsNCT03417622
What this trial is testing

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Who this might be right for
Breast Cancer
Mansoura University 370
Not applicableStudy completedNCT02567929
What this trial is testing

Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer

Who this might be right for
Breast Cancer
Konkuk University Medical Center 218
Early research (Phase 1)Study completedNCT07300202
What this trial is testing

CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]

Who this might be right for
Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult VolunteersBreast Cancer
Oriplantee Company Limited 15
Not applicableStudy completedNCT01713959
What this trial is testing

Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis

Who this might be right for
Hyperhidrosis
Ulthera, Inc 15
Large-scale testing (Phase 3)Study completedNCT02584959
What this trial is testing

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 75
Not applicableNot Yet RecruitingNCT06973473
What this trial is testing

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

Who this might be right for
Warts
Assiut University 60
Load More Results